CompoSecure, Inc. (NASDAQ:CMPO - Free Report) - Research analysts at B. Riley reduced their FY2024 EPS estimates for CompoSecure in a report issued on Monday, November 11th. B. Riley analyst H. Goetsch now anticipates that the company will earn $1.03 per share for the year, down from their prior estimate of $1.09. B. Riley currently has a "Buy" rating and a $23.00 target price on the stock. The consensus estimate for CompoSecure's current full-year earnings is $1.02 per share. B. Riley also issued estimates for CompoSecure's Q4 2024 earnings at $0.24 EPS and FY2025 earnings at $1.08 EPS.
CompoSecure (NASDAQ:CMPO - Get Free Report) last posted its quarterly earnings data on Friday, November 8th. The company reported $0.27 earnings per share for the quarter, missing the consensus estimate of $0.29 by ($0.02). CompoSecure had a negative return on equity of 14.87% and a negative net margin of 5.63%. The business had revenue of $107.14 million during the quarter, compared to analysts' expectations of $105.11 million. During the same period in the prior year, the firm posted $0.24 EPS.
CMPO has been the subject of several other reports. Needham & Company LLC reaffirmed a "buy" rating and set a $16.00 price objective on shares of CompoSecure in a research note on Monday. Compass Point lifted their target price on shares of CompoSecure from $11.50 to $14.50 and gave the company a "buy" rating in a report on Tuesday, August 20th. Bank of America raised their price objective on CompoSecure from $9.00 to $10.00 and gave the company a "buy" rating in a research report on Thursday, August 8th. Benchmark reiterated a "buy" rating and issued a $17.00 target price on shares of CompoSecure in a research note on Tuesday. Finally, JPMorgan Chase & Co. lifted their target price on CompoSecure from $8.00 to $12.00 and gave the stock a "neutral" rating in a report on Tuesday, August 20th. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $15.79.
View Our Latest Report on CompoSecure
CompoSecure Stock Performance
Shares of CMPO traded down $0.50 during mid-day trading on Wednesday, hitting $13.73. The stock had a trading volume of 549,213 shares, compared to its average volume of 523,939. CompoSecure has a 52 week low of $4.61 and a 52 week high of $16.14. The business has a fifty day moving average price of $13.98 and a 200-day moving average price of $10.03.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of CMPO. Wealth Enhancement Advisory Services LLC grew its stake in shares of CompoSecure by 1.7% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 40,944 shares of the company's stock valued at $574,000 after purchasing an additional 701 shares during the last quarter. CWM LLC grew its position in CompoSecure by 42.0% in the 3rd quarter. CWM LLC now owns 5,192 shares of the company's stock valued at $73,000 after buying an additional 1,536 shares during the last quarter. Bard Associates Inc. increased its stake in CompoSecure by 0.6% in the 3rd quarter. Bard Associates Inc. now owns 305,247 shares of the company's stock valued at $4,280,000 after buying an additional 1,957 shares during the period. Rhumbline Advisers raised its position in CompoSecure by 17.3% during the 2nd quarter. Rhumbline Advisers now owns 19,521 shares of the company's stock worth $133,000 after buying an additional 2,877 shares during the last quarter. Finally, nVerses Capital LLC acquired a new stake in shares of CompoSecure in the 3rd quarter worth $72,000. 37.56% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at CompoSecure
In other news, Director Michele Logan sold 10,017,983 shares of the business's stock in a transaction dated Tuesday, September 17th. The shares were sold at an average price of $7.55, for a total transaction of $75,635,771.65. Following the transaction, the director now owns 2,043,320 shares of the company's stock, valued at approximately $15,427,066. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other CompoSecure news, Director Michele Logan sold 10,017,983 shares of the company's stock in a transaction dated Tuesday, September 17th. The shares were sold at an average price of $7.55, for a total value of $75,635,771.65. Following the transaction, the director now owns 2,043,320 shares of the company's stock, valued at $15,427,066. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Adam Joseph Lowe sold 5,730 shares of CompoSecure stock in a transaction dated Wednesday, September 11th. The shares were sold at an average price of $12.05, for a total transaction of $69,046.50. Following the sale, the insider now owns 1,292,219 shares of the company's stock, valued at approximately $15,571,238.95. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 10,691,727 shares of company stock worth $80,922,824. Insiders own 74.99% of the company's stock.
CompoSecure Company Profile
(
Get Free Report)
CompoSecure, Inc manufactures and designs metal, composite, and proprietary financial transaction cards in the United States and internationally. Its primary metal form factors include embedded, metal veneer lite, metal veneer, and full metal products. The company also offers Arculus Cold Storage Wallet, a three-factor authentication solution, which supports specific digital assets, including Bitcoin, Ethereum, non-fungible tokens and others.
Further Reading
Before you consider CompoSecure, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CompoSecure wasn't on the list.
While CompoSecure currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.